Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.

Jorge E CortesFlorian H HeidelWalter FiedlerB Douglas SmithTadeusz RobakPau MontesinosAnna CandoniBrian LeberMikkael A SekeresDaniel A PollyeaRoxanne FerdinandWeidong Wendy MaThomas O'BrienAshleigh O'ConnellGeoffrey ChanMichael Heuser

Published in: Journal of hematology & oncology (2020)

ClinicalTrials.gov NCT01546038 (March 7, 2012).

Keyphrases

acute myeloid leukemia
low dose
high dose
allogeneic hematopoietic stem cell transplantation
newly diagnosed
mesenchymal stem cells
smoking cessation